Write For Us

Alzheimer's drug Donanemab found to be a 'turning point' in clinical trials

Sponsored Post Vitamin D2 Canada Persia
34 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
A new drug has been hailed as a turning point in the fight against Alzheimer's, slowing cognitive decline in trials by up to 35%.

The medicine, called Donanemab, slowed down cognitive decline in trials by up to 35% - allowing patients to live independently for longer.

Alzheimer's Research UK has said treatments like this mean one day the conditions could be treatable like other long-term such as asthma or diabetes.

Read more about dementia here: https://news.sky.com/topic/dementia-6062

#dementia #alzheimer #nhs #breakthrough

SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews

Follow us on Twitter: https://twitter.com/skynews
Like us on Facebook: https://www.facebook.com/skynews
Follow us on Instagram: https://www.instagram.com/skynews
Follow us on TikTok: https://www.tiktok.com/@skynews

For more content go to http://news.sky.com and download our apps: Apple https://itunes.apple.com/gb/app/sky-news/id316391924?mt=8 Android https://play.google.com/store/apps/details?id=com.bskyb.skynews.android&hl=en_GB

Sky News Daily podcast is available for free here: https://podfollow.com/skynewsdaily/

Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí: https://www.youtube.com/channel/UCzG5BnqHO8oNlrPDW9CYJog

To enquire about licensing Sky News content, you can find more information here: https://news.sky.com/info/library-sales
Category
World
Tags
Sky, Alzheimer's disease, NHS
Sign in or sign up to post comments.
Be the first to comment